CompletedPhase 2NCT00107432

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Studying Pleural mesothelioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Pasi Janne, MD PHD
Cancer and Leukemia Group B
Intervention
sorafenib tosylate(drug)
Enrollment
44 enrolled
Eligibility
18 years · All sexes
Timeline
2004

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00107432 on ClinicalTrials.gov

Other trials for Pleural mesothelioma

Additional recruiting or active studies for the same condition.

See all trials for Pleural mesothelioma →

← Back to all trials